Skip to main content

Table 1 Characteristics of the participants

From: Levels of circulating insulin cell-free DNA in women with polycystic ovary syndrome – a longitudinal cohort study

 

Baseline

Follow-up

Baseline vs. Follow-up

Control

n = 8

PCOS

n = 40

p

Control

n = 8

PCOS

n = 40

p

Controls

p

PCOS

p

Age (years)

30.0 (5.2)

29.1 (4.1)

NS

35.6 (6.0)

34.7 (4.2)

NS

Weight (kg)

72.3 (12.4)

77.6 (20.1)

NS

79.2 (12.8)

78.5 (17.8)

NS

0.03

NS

Height (cm)

169.8 (3.8)

168.5 (7.1)

NS

171.3 (4.3)

168.5 (6.9)

NS

NS

NS

BMI (kg/m2)

24.83 (4.2)

26.7 (5.2)

NS

27.0 (4.3)

27.7 (6.1)

NS

0.03

0.013

Waist (cm)

83.4 (8.5)

89.5 (12.8)

NS

90.8 (11.0)

91.7 (15.0)

NS

0.02

0.018

Hip (cm)

106.6 (7.8)

107.8 (9.1)

NS

108.0 (8.0)

109.2 (11.5)

NS

NS

0.018

Waist-Hip Ratio

0.8 (0.1)

0.8 (0.1)

NS

0.8 (0.6)

0.8 (0.1)

NS

0.06

NS

Systolic Blood Pressure (mmHg)

123.2 (17.2)

122.5 (11.0)

NS

113.6 (18.1)

121.0 (12.9)

NS

NS

NS

Diastolic Blood Pressure (mmHg)

76.6 (13.5)

77.0 (10.8)

NS

71.5 (17.1)

72.8 (11.2)

NS

NS

0.04

Ferriman Gallwey Score

2.5 (1.5–4.5)

5.0 (3.0–10.0)

0.019

1.5 (0–5.5)

6.0 (3.0–9.0)

NS

NS

NS

Total testosterone (nmol/L)

0.9 (0.7–1.6)

1.9 (1.4–2.5)

0.001

0.7 (0.4–0.9)

1.4 (1.0–2.0)

0.02

0.039

< 0.001

Free testosterone (nmol/L)

0.019 (0.012–0.023)

0.032 (0.019–0.050)

0.016

0.012 (0.007–0.014)

0.023 (0.014–0.036)

NS

NS

0.008

DHEAS (Umol/L)

5181 (1962)

5676 (2764)

NS

4437 (2550)

4857 (2190)

NS

NS

0.017

Androstenedione (nmol/L)

4.4 (3.0–5.7)

7.1 (4.7–9.0)

0.008

2.8 (1.8–3.4)

5.8 (4.0–8.5)

< 0.001

0.001

0.048

SHBG (nmol/L)

62.5 (45.0–73.5)

59.5 (40.0–83.0)

NS

49.0 (30.0–72.5)

46.0 (36.5–83.0)

NS

NS

0.011

LH/FSH ratio

0.7 (0.5–1.2)

1.7 (1.2–2.3)

< 0.001

0.8 (0.8–1.1)

1.6 (1.1–2.2)

0.02

NS

NS

Fasting s-glucose (mmol/L)

5.3 (0.8)

5.1 (0.4)

NS

4.8 (0.7)

4.9 (0.5)

NS

NS

0.029

s-insulin (pmol/L)

58.8 (40.8–84.1)

45.7 (33.0–104.1)

NS

56.7 (38.6–110.9)

60.1 (37.7–108.9)

NS

NS

0.014

s-C-peptide (nmol/L)

0.6 (0.6–0.7)

0.6 (0.4–0.8)

NS

0.7 (0.6–0.7)

0.7 (0.5–1.0)

NS

NS

< 0.001

HOMA IR

(mU*mmol/L2)

13.9 (10.1–18.9)

10.3 (7.4–22.7)

NS

11.0 (8.2–27.8)

12.9 (7.6–24.8)

NS

NS

0.056

Total cholesterol (mmol/L)

4.7 (0.7)

4.6 (0.8)

NS

4.3 (0.8)

4.5 (0.8)

NS

NS

NS

LDL cholesterol (mmol/L)

2.9 (0.7)

2.6 (0.7)

NS

2.5 (0.7)

2.6 (0.8)

NS

NS

NS

HDL cholesterol (mmol/L)

1.4 (0.2)

1.60 (0.5)

NS

1.4 (0.3)

1.6 (1.2)

NS

NS

NS

Triglyceride (mmol/L)

0.70 (0.7–0.8)

0.7 (0.6–1.2)

NS

0.9 (0.9–1.2)

0.8 (0.7–1.6)

NS

NS

0.001

  1. Legend: Baseline characteristics of the study participants. Data are presented as mean ± SD or as medians (interquartile range) if not normally distributed. Values were considered significantly different at P < 0.05. Abbreviations: HOMA-IR homeostatic model assessment of insulin resistance, HDL high-density lipoprotein, LDL low-density lipoprotein, LH Luteinizing Hormone, FSH Follicle Stimulating Hormone, DHEAS Dehydroepiandrosterone, SHBG Sex Hormone-Binding Globulin, NS not significant